First Supplemental HTLV-I/II Infection Test Approved

The Food and Drug Administration (FDA) has approved MP Diagnostics HTLV Blot 2.4, the first supplemental test for Human T-Cell Lymphotropic Virus-I/II (HTLV-I/II).

The HTLV Blot 2.4 is a qualitative enzyme immunoassay test indicated for use as a more specific test for human serum or plasma specimens that have previously tested positive on a licensed HTLV-I/II blood donor screening test. It is meant to confirm HTLV infection and to differentiate between HTLV-I and HTLV-II.

There are currently two FDA-licensed screening tests for HTLV-I/II used in testing blood samples from a donor. If the sample tests positive, the HTLV Blot 2.4 can distinguish which virus type is causing the infection and can provide further information to the donor.

For more information visit FDA.gov.

Want to read more?